When my mother died of colon cancer, I saw firsthand the devastation that comes when treatment options run out. For decades, I’ve worked to spare others that same fate — helping patients around the world get the right medicine at the right time.
That’s why I’m deeply concerned by President Donald Trump’s push to tie U.S. drug prices to those set by foreign governments.
Trending: Sex-obsessed prison warden filmed romping with inmate admits she’s ‘incredibly embarrassed’
The concern isn’t the goal itself. Trump is right that other wealthy nations have long benefited from American pharmaceutical innovation without paying their fair share for it.
TRUMP’S ‘MOST FAVORED NATION’ DRUG PRICING PUSH RISKS UNDERMINING PRO-LIFE LEGACY
Bringing a new drug to market is enormously resource-intensive, requiring an average investment of nearly $2.7 billion. Yet governments in Europe, Japan, and elsewhere routinely impose arbitrary price controls on medicines, paying a fraction of what Americans do. Foreign governments achieve these lower prices by delaying access and devaluing medicines
Continue reading
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!